Blood And Lymphatic Cancer-targets And Therapy

Journal Title：Blood And Lymphatic Cancer-targets And Therapy

Blood and lymphatic system cancers - targets and treatments "is a cutting-edge academic journal focused on research in the field of blood and lymphatic system cancers. With the global incidence rate of blood tumors (such as leukemia, lymphoma, etc.) rising year by year, the magazine came into being and is committed to promoting scientific research and clinical treatment progress in this field. Its published content covers various aspects of cancer, such as molecular mechanisms, novel therapeutic targets, innovative therapies, and clinical trials, providing researchers, clinical doctors, and patients with the latest scientific research achievements and diagnosis and treatment information. This magazine is published by authoritative institutions and undergoes rigorous peer review to ensure the scientific and reliable nature of its published content. As a professional journal in this field, 'Hematological and Lymphatic System Cancer - Targets and Treatment' plays an important role in promoting research and development in hematological oncology.

《血液和淋巴系统癌症-靶点和治疗》是一本专注于血液和淋巴系统癌症领域研究的前沿学术期刊。随着血液肿瘤（如白血病、淋巴瘤等）在全球范围内的发病率逐年上升，该杂志应运而生，致力于推动该领域的科学研究与临床治疗进步。其发表内容涵盖癌症的分子机制、新型治疗靶点、创新疗法及临床试验等各个方面，为研究者、临床医生和患者提供最新的科研成果和诊疗信息。该杂志由权威机构出版，经过严格的同行评审，确保了所发表内容的科学性和可靠性。作为该领域的专业期刊，《血液和淋巴系统癌症-靶点和治疗》在推动血液肿瘤研究与发展方面发挥着重要作用。

Blood And Lymphatic Cancer-targets And Therapy由Dove Medical Press出版商出版，收稿方向涵盖ONCOLOGY全领域，平均审稿速度 16 Weeks ，影响因子指数3.9，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。